Hanyang Med Rev.
2005 Aug;25(3):27-36.
Mucopolysaccharidosis and mucolipidosis
- Affiliations
-
- 1Clinical Research Center, Samsung Biomedical Research Institute, Seoul Korea.
- 2Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Korea. jindk@smc.samsung.co.kr
Abstract
- Mucopolysaccharidosis (MPS) and mucolipidosis(ML) belong to a group of rare genetic disorders of lysosomal enzymes and share some clinical manifestations. MPS is characterized by the accumulation of glycosaminoglycans (GAG) and results from the impaired function of one of 11 enzymes required for normal GAG degradation. ML, which is clinically similar to several forms of MPS, is caused by deficiency of Nacetylglucosamine-1-phosphotransferase activity. Therapeutic strategies for MPS, including enzyme replacement therapy and bone marrow transplantation, have been developed with some success. In this review, we discuss clinical feature, diagnostic methods, management and the present status of research on MPS and ML.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Mucopolysaccharidosis Type I with Spinal Cord Compression
- Ocular Findings in Mucolipidosis Type II
- Carpal Tunnel Syndrome Caused by Persistent Median Artery and Bifid Median Nerve in an Adolescent
- A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth
- A case of Hunter's Syndrome: Mucopolysaccharidosis type II
